[email protected]
Carl Schmid
Deputy Executive Director of The AIDS Institute & Co-Chair of the Presidential Advisory Council on HIV/AIDS
Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years. He spent 16 years with The AIDS Institute, where he served as its Deputy Executive Director and led the Institute’s HIV and viral hepatitis federal policy work before the executive agencies and the Congress. In January 2020, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Mr. Schmid helps lead the HIV and hepatitis communities’ advocacy efforts in Washington, D.C., to ensure domestic HIV and hepatitis programs, including the Ending the HIV Epidemic initiative, the Ryan White Program, CDC HIV and hepatitis prevention programs, and NIH AIDS Research are based on sound public policy and fully funded. He serves on the Convening Group of the Federal AIDS Policy Partnership (FAPP) and co-chairs its AIDS Budget and Appropriations Coalition.
He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of people living with or at risk of HIV and hepatitis. As part of HIV+Hep’s work in advocating for people with HIV and hepatitis, Mr. Schmid works extensively with other patient and disease groups on collective efforts to ensure that patients, particularly those with chronic conditions, have access to quality and affordable healthcare, including prescription medications.
From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). He currently serves as a member of PACHA, as he did in 2007-09, and chaired its Domestic Subcommittee.
In January 2021, Mr. Schmid was selected as a consumer representative to the National Association of Insurance Commissioners, a post he served during 2018-19. In July 2019, he was appointed to the PEPFAR Scientific Advisory Board.
In 2010, he was named by POZ magazine as one of the 100 most effective AIDS fighters and by Whitman-Walker Health as one of the 25 individuals who have played prominent roles in the fight against HIV in D.C. In 2016, he was named the Champion of the Year by the ADAP Advocacy Association.
He is a cancer survivor and living with chronic hepatitis B.
Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.
Related Speakers View all
Matthew Eyles
President and CEO, America's Health Insurance Plans
|
|
Sofia Imad
Junior Fellow at IDFC Institute
|
|
Kim Keck
President & CEO of the BlueCross BlueShield Association
|
|
John Mattison
Chief Medical Information Officer & Assistant Medica...
|
|
Geannie Cho
Chief Operating Officer of LINA (Cigna Korea)
|
|
Barry H. Ostrowsky
President & Chief Executive Officer of RWJ Barnabas ...
|
|
Thomas M. Moriarty
Executive Vice President, Chief Policy and External ...
|
|
Daniel Mendelson
CEO of Morgan Health at JPMorgan Chase
|
|
Mario Schlosser
Co-Founder & CEO of Oscar Health Insurance
|
|
Michael Tutty
Group Vice President, Professional Satisfaction and ...
|
|
Louis W. Sullivan
Chairman of the Board, National Health Museum; Forme...
|
|
Erica Frenkel
Chief Operating Officer at Gradian Health Systems
|
|
Giovanni Colella
Co-Founder & CEO at Castlight Health
|
|
Toby Cosgrove
Executive Advisor & Former CEO & President at Clevel...
|
|
Scott W. Atlas
Medical Adviser, President Trump's Coronavirus Task ...
|
|
Elizabeth Nabel
Cardiologist & Chief Strategy Officer at ModeX Thera...
|
|
Adewale Troutman, MD, MPH, MA, CPH
President, American Public Health Association (APHA)...
|
|
Jack Choi
CEO of Anatomage, a company specializing on 3D medic...
|
|
Patrick Kennedy
Former Congressman (D-RI); Founder of The Kennedy Fo...
|
|
William Frist
Chair, The Nature Conservancy Global Board;
Former...
|